Alector, Inc. Capital Expenditures
Alector, Inc. (ALEC) reported Capital Expenditures of $149.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Alector, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $31.00K, a 210.00% increase year-over-year.
- Alector, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $118.00K, a 490.00% increase year-over-year.
- Alector, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Alector, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $11.00K, a 94.81% decline year-over-year.
- Alector, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $41.00K, a 96.73% decline from fiscal 2024.
- Alector, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $1.25M, a 47.29% decline from fiscal 2023.
- Alector, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $2.38M, a 42.17% decline from fiscal 2022.
- Alector, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $4.12M, a 26.79% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $149.00K 10-Q · filed 2026-08-06 | $149.00K derived: sum of 3 quarters · filed 2026-08-06 | $160.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $118.00K 10-Q · filed 2026-05-07 | $118.00K derived: sum of 2 quarters · filed 2026-05-07 | $129.00K derived: sum of 3 quarters · filed 2026-05-07 | $139.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $11.00K derived: sum of 2 quarters · filed 2026-02-25 | $21.00K derived: sum of 3 quarters · filed 2026-08-06 | $41.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $21.00K derived: sum of 2 quarters · filed 2026-08-06 | $41.00K 10-Q · filed 2025-11-06 | $214.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $30.00K 10-Q · filed 2026-08-06 | $203.00K derived: sum of 3 quarters · filed 2026-08-06 | $415.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $20.00K 10-Q · filed 2026-05-07 | $193.00K derived: sum of 2 quarters · filed 2026-05-07 | $405.00K derived: sum of 3 quarters · filed 2026-05-07 | $742.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $173.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $385.00K derived: sum of 2 quarters · filed 2026-02-25 | $722.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.25M 10-K · filed 2026-02-25 |
| 2024-09-30 | $212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $549.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.08M 10-Q · filed 2025-11-06 | $1.31M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $337.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $870.00K 10-Q · filed 2025-08-07 | $1.10M derived: sum of 3 quarters · filed 2025-08-07 | $1.01M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $533.00K 10-Q · filed 2025-05-08 | $766.00K derived: sum of 2 quarters · filed 2025-05-08 | $672.00K derived: sum of 3 quarters · filed 2025-05-08 | $1.89M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $139.00K derived: sum of 2 quarters · filed 2025-02-26 | $1.36M derived: sum of 3 quarters · filed 2025-02-26 | $2.38M 10-K · filed 2025-02-26 |
| 2023-09-30 | -$94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.12M derived: sum of 2 quarters · filed 2024-11-06 | $2.15M 10-Q · filed 2024-11-06 | $2.91M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $2.24M 10-Q · filed 2024-08-07 | $3.01M derived: sum of 3 quarters · filed 2025-02-26 | $4.92M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $1.02M 10-Q · filed 2024-05-08 | $1.79M derived: sum of 2 quarters · filed 2025-02-26 | $3.71M derived: sum of 3 quarters · filed 2025-02-26 | $4.45M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $2.68M derived: sum of 2 quarters · filed 2025-02-26 | $3.42M derived: sum of 3 quarters · filed 2025-02-26 | $4.12M 10-K · filed 2025-02-26 |
| 2022-09-30 | $1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.66M derived: sum of 2 quarters · filed 2023-11-07 | $3.35M 10-Q · filed 2023-11-07 | $3.91M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $744.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.44M 10-Q · filed 2023-08-03 | $1.99M derived: sum of 3 quarters · filed 2024-02-27 | $2.91M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $692.00K 10-Q · filed 2023-05-04 | $1.25M derived: sum of 2 quarters · filed 2024-02-27 | $2.16M derived: sum of 3 quarters · filed 2024-02-27 | $2.99M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $557.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.47M derived: sum of 2 quarters · filed 2024-02-27 | $2.30M derived: sum of 3 quarters · filed 2024-02-27 | $3.25M 10-K · filed 2024-02-27 |
| 2021-09-30 | $915.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.74M derived: sum of 2 quarters · filed 2022-11-08 | $2.69M 10-Q · filed 2022-11-08 | $3.48M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $828.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.77M 10-Q · filed 2022-08-04 | $2.56M derived: sum of 3 quarters · filed 2023-02-28 | $2.94M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $947.00K 10-Q · filed 2022-05-05 | $1.74M derived: sum of 2 quarters · filed 2023-02-28 | $2.12M derived: sum of 3 quarters · filed 2023-02-28 | $2.41M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $788.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.17M derived: sum of 2 quarters · filed 2023-02-28 | $1.47M derived: sum of 3 quarters · filed 2023-02-28 | $5.03M 10-K · filed 2023-02-28 |
| 2020-09-30 | $381.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $678.00K derived: sum of 2 quarters · filed 2021-11-04 | $4.24M 10-Q · filed 2021-11-04 | $5.82M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $297.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $3.86M 10-Q · filed 2021-08-03 | $5.44M derived: sum of 3 quarters · filed 2022-02-24 | $7.74M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $3.57M 10-Q · filed 2021-05-05 | $5.14M derived: sum of 2 quarters · filed 2022-02-24 | $7.44M derived: sum of 3 quarters · filed 2022-02-24 | $16.80M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.87M derived: sum of 2 quarters · filed 2022-02-24 | $13.23M derived: sum of 3 quarters · filed 2022-02-24 | $15.27M 10-K · filed 2022-02-24 |
| 2019-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $11.66M derived: sum of 2 quarters · filed 2020-11-10 | $13.69M 10-Q · filed 2020-11-10 | $14.11M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $9.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $11.39M 10-Q · filed 2020-08-11 | $11.81M derived: sum of 3 quarters · filed 2021-02-25 | $11.97M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.03M 10-Q · filed 2020-05-13 | $2.45M derived: sum of 2 quarters · filed 2021-02-25 | $2.60M derived: sum of 3 quarters · filed 2021-02-25 | $3.30M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $574.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.27M derived: sum of 3 quarters · filed 2021-02-25 | $1.88M 10-K · filed 2021-02-25 |
| 2018-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $854.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.47M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $697.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $1.31M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $613.00K 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $801.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |